Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

ProSomnus (OSA) Stock Forecast & Price Target

ProSomnus logo
Get the Latest News and Ratings for OSA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for ProSomnus and its competitors.

Sign Up

OSA Analyst Ratings Over Time

TypeCurrent Forecast
12/23/23 to 12/22/24
1 Month Ago
11/23/23 to 11/22/24
3 Months Ago
9/24/23 to 9/23/24
1 Year Ago
12/23/22 to 12/23/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$2.00$2.00$2.33$2.50
Forecasted UpsideN/A14,605.88% Upside17,056.86% Upside177.76% Upside
Consensus Rating
Buy
Buy
Moderate Buy
Moderate Buy

OSA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OSA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

ProSomnus Stock vs. The Competition

TypeProSomnusMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.81
2.51
Consensus RatingBuyModerate BuyModerate Buy
Predicted UpsideN/A25,827.32% Upside14.53% Upside
News Sentiment Rating
Neutral News

See Recent OSA News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/22/2024Alliance Global Partners
1 of 5 stars
 Initiated CoverageBuy$2.00+194.11%
11/10/2023Craig Hallum
3 of 5 stars
 Reiterated RatingBuy ➝ Hold$1.00+177.77%
9/26/2023Roth Mkm
1 of 5 stars
 Lower TargetBuy ➝ Buy$6.00 ➝ $4.00+308.16%
4/18/2023Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Henry
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:02 AM ET.


OSA Forecast - Frequently Asked Questions

According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for ProSomnus is $2.00, with a high forecast of $2.00 and a low forecast of $2.00.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ProSomnus in the last year. There is currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" OSA shares.

According to analysts, ProSomnus's stock has a predicted upside of ∞ based on their 12-month stock forecasts.

Analysts like ProSomnus more than other "medical" companies. The consensus rating for ProSomnus is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how OSA compares to other companies.


This page (NASDAQ:OSA) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners